Drug delivery focuses on transporting therapeutic agents to the right location, at the right dose, and for the right duration in the body. In nanotechnology, drug delivery uses nanoparticles, liposomes, polymeric carriers, dendrimers, hydrogels, micelles, exosomes, and implantable systems to control solubility, stability, targeting, release, and biological interactions. Delivery systems can carry small molecules, proteins, peptides, nucleic acids, vaccines, or imaging agents.
Drug delivery matters because many promising therapies fail without effective transport through biological barriers and controlled exposure at target tissues. Nanoscale carriers can improve circulation time, protect fragile cargo, reduce systemic toxicity, enable combination therapies, and support stimuli-responsive release. Key challenges include immune recognition, clearance, biodistribution, scalability, reproducibility, and safety. The topic connects closely to nanomedicine, lipid nanoparticles, polymeric nanoparticles, and surface functionalization.
Conferences on drug delivery appear in pharmaceutical science, nanotechnology, biotechnology, medicine, biomaterials, and chemical-engineering programs. Sessions often cover targeted delivery, RNA delivery, cancer nanomedicine, controlled release, formulation, safety, and translation. Tracking drug-delivery events helps researchers follow how nanoscale engineering is reshaping therapeutic design and clinical implementation.
To learn more, read our detailed glossary article on drug delivery.